Minimizing the risk of human DNA contamination in products used to collect, store and analyze biological material for forensic purposes - Requirements
Introduction: This International Standard was produced with the aim to create global standards for manufacturers of forensic products used in human DNA analysis. Inadvertent contamination by manufacturers of consumables and reagents, when combined with the improved sensitivity of DNA testing methods, increasingly interferes with forensic analysis. © ISO 2016 – All rights reserved
Scope: This International Standard specifies requirements for the production of products used in the collection, storage, and analysis of biological material for forensic DNA purposes, but not those consumables and reagents used in post-amplification analysis. The consumables and reagents covered by this International Standard include those used for evidence collection (sampling kits), such as swabs, containers, and packaging, and also products used in the analysis of DNA samples, such as tubes and other plasticware, disposable laboratory coats, gloves, and other consumables. This International Standard applies to the production of consumables and reagents which do not require cleaning for continued use. This International Standard does not cover technical product specifications (i.e. product design). This International Standard excludes microbiological testing. This International Standard specifies a requirement for manufacturers to minimize the risk of occurrence of detectable human nuclear DNA contamination in products used by the global forensic community. An overview of the International Standard is provided in Figure 1. ISO 18385:2016(E) © ISO 2016 – All rights reserved ISO 18385:2016(E) 5.4 Subcontracting of work and purchase of components 5.6 Corrective and preventative action Fail Fail Pass Clause 8 Requirements for products subject to post-production treatment Clause 10 Product packaging, labelling and documentation Clause 9 Requirements for products not subject to post-production treatment Clause 6 Human DNA contamination risk management 6.2 Risk assessment: Acceptable 6.2 Risk assessment: Conditionally acceptable 6.2 Risk assessment: Unacceptable Consider for further risk reduction Manufacturing A.3 Validation of post-production treatments Clause 7 Environmental human DNA monitoring Pass Post- production treatment 6.3 Risk mitigation 5.5 Control of nonconforming product yes no Figure 1 — Overview of the processes covered by this International Standard 2 Terms and definitions For the purposes of this document, the following terms and definitions apply. 2.1 allele one of a number of alternatives at a specific location on an individual’s DNA 2.2 amplification